SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Net Margin Over TimeStrong
Percentile Rank83
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-684.96%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-2579.03%-36.9%
2023-1884.50%-2303.7%
2022-78.40%-178.4%
2021-28.16%-177.3%
202036.42%+114.0%
2019-261.07%-